Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Haematologica ; 86(4): 420-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11325650

ABSTRACT

BACKGROUND AND OBJECTIVES: von Willebrand's disease (vWD) is a bleeding disorder with variable clinical expression. Our aim was to classify patients with vWD and to determine the phenotype in their relatives. DESIGN AND METHODS: The types and subtypes, blood group frequency and its relevance, bleeding sites, response to the desmopressin (DDAVP) test, transfusion requirements and clinical features in type 1 and 2A families were determined in 1,885 patients. RESULTS: Our findings were: type 1: 91%, type 2A: 3.1%, severe vWD: 1.3%; type 2N: 1.6%; type low intraplatelet: 2.7%; combined 1+ 2N: 0.3%. Blood group O prevalence was 70.5%. Bleeding and transfusion requirements were not correlated to blood groups. The most frequent symptoms were: ecchymoses-hematomas and epistaxis and, in females over 13 years, also menorrhagia. Normal levels of factor VIII:C were found in 38.4% of the patients. DDAVP was infused in 567 patients with a good response in 80.6%. About 9% of our patients needed transfusion therapy. The diagnosis of von Willebrand's disease is more likely in subjects belonging to families with type 2A disease than in members of families with type 1 vWD in spite of these being symptomatic. INTERPRETATION AND CONCLUSIONS: These observations provide a good strategy to identify, classify and treat vWD patients without performing molecular assays.


Subject(s)
von Willebrand Diseases/genetics , Argentina/epidemiology , Blood Group Antigens/analysis , Cohort Studies , Family Health , Female , Hemorrhage/etiology , Humans , Male , Phenotype , Prevalence , von Willebrand Diseases/blood , von Willebrand Diseases/epidemiology
4.
Am J Clin Pathol ; 111(3): 418-23, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10078119

ABSTRACT

We developed a new method for the detection of large von Willebrand factor (vWf) multimers binding to collagen and for the determination of vWf antigen (vWf:Ag) using flow cytometry. Collagen is coated on to polystyrene beads, allowing detection of found large vWf multimers. In addition, rabbit antibody against vWf is coated on to the beads allowing detection of all vWf:Ag. In plasma samples from healthy persons and patients (with type 1, 2A, 2N, or severe von Willebrand disease or hemophilia), 4 different assays were performed: vWf:Ag by immunoelectrophoresis; vWf ristocetin cofactor (vWf:RCof); CBA; and vWf:Ag based on an enzyme-linked immunosorbent assay using polystyrene beads. We assayed the flow cytometric method using 2 bead sizes. The optimal bead size was 3.136 microns. The results of CBA and vWf:Ag closely correlated with those of vWf:RCof and vWf:Ag (immunoelectrophoresis), respectively, and showed a low limit of detection. Interassay variance of cytometric methods was lower than interassay variance of traditional assays. In addition, we used the new assays to monitor desmopressin therapy.


Subject(s)
Collagen/metabolism , Flow Cytometry/methods , von Willebrand Factor/metabolism , Animals , Deamino Arginine Vasopressin/therapeutic use , Enzyme-Linked Immunosorbent Assay , Hemophilia A/blood , Hemophilia A/diagnosis , Humans , Immunoelectrophoresis , Microspheres , Molecular Weight , Polystyrenes , Protein Binding , Rabbits , Reference Values , Sensitivity and Specificity , von Willebrand Diseases/blood , von Willebrand Diseases/diagnosis , von Willebrand Diseases/drug therapy , von Willebrand Factor/analysis , von Willebrand Factor/immunology
6.
Medicina (B Aires) ; 57(4): 409-16, 1997.
Article in English | MEDLINE | ID: mdl-9674262

ABSTRACT

The perfusion of serum, citrated whole blood and citrated plasma, through a simple tube system resulted in a significant loss of large von Willebrand factor (vWf) multimers, without decrease in antigen levels. Maximum loss of large multimers was observed at a shear rate of 15,000 s-1 for 15 min. Heparin, aprotinin, soybean trypsin inhibitor, phenylmethylsulphonylfluoride, N-ethylmaleimide, leupeptin or calpain inhibitor peptide could not prevent the loss of large vWf multimers in citrated plasma. The addition of EDTA calcium salt partially prevented it, and it was totally prevented by EDTA without calcium. Perfusion of purified vWf did not induce the loss of large multimers, but this did happen after the addition of either whole serum or a plasma fraction. The activity of this plasma fraction disappeared at pH < 6.8. Besides, we have found that the binding to subendothelium of purified vWf diluted in dialyzed serum was lower at pH 7.2 than at pH 6.0. Chromatographic studies demonstrated that the loss of large vWf multimers, induced by high shear rates, involves a plasma substance(s) of molecular weight larger than 200 kD; calpain and granulocyte or cysteine proteases do not seem to be this plasma substance(s).


Subject(s)
Perfusion/methods , Plasma/chemistry , von Willebrand Factor/analysis , von Willebrand Factor/isolation & purification , In Vitro Techniques
SELECTION OF CITATIONS
SEARCH DETAIL
...